Erectile Dysfunction, Sexual Symptoms Linked to Increased Mortality in Men

March 31, 2020


New data from ENDO 2020 suggests the presence of erectile dysfunction and sexual symptoms was linked to increased risk of death.

Low Fat, Mediterranean Diets Linked to Low Testosterone in Men

January 11, 2020


A recent analysis of participants in the NHANES database found low fat and Mediterranean diets were linked to lower serum testosterone levels in men.

ACP Releases Guidelines for Treatment of Age-Related Low Testosterone

January 07, 2020


The American College of Physicians has released guidelines, which include 4 new recommendations, for the treatment of age-related low testosterone in men.

FDA Approves Testosterone Undecanoate for Hypogonadism

March 27, 2019


Jatenzo's label will be marketed with a boxed warning stating it can cause risen blood pressure, thereby increasing heart attack, stroke, and cardiovascular death risks.

Self-Administered Testosterone Therapy Gets FDA Nod on Second Try

October 02, 2018


XYOSTED's approval comes nearly a year following Antares first received a Complete Response Letter from the FDA for its application.

Lipocine Receives FDA Complete Response Letter for Testosterone Therapy Candidate

May 10, 2018


TLANDO is being investigated for the treatment of adult men with deficiencies of endogenous testosterone.

FDA Committee Advises Against Lipocene Testosterone Replacement Therapy

January 11, 2018


Lipocene's TLANDO was recommended against by a vote of 13-6.

Testosterone Intention-to-Treat Trial: Duration of Treatment Matters

May 30, 2017


Experts caution duration of testosterone replacement therapy.

Hypogonadism, Diabetes: Chronic Diseases That Need to be Treated For Life

April 01, 2017


The type 1 diabetes patients who were continuously administered testosterone treatment showed improvements in glycemic control as well as massive improvements in their weight loss, since testosterone increases lean body mass.

Long-Term Testosterone Therapy: Effects on Hypogonadal Men with Type 1 Diabetes

April 01, 2017


Farid Saad, DVM, PhD, Bayer Pharma AG learned that the men with type 1 diabetes did experience benefits of long-term testosterone therapy – they showed improvements in their underlying diseases.